Checked
Class IDrug recallTerminated
Ascorbic Acid Inj. Solution recall
Recalled by Staska Pharmaceuticals, Inc. of Bennet, NE · FDA report 11/13/2024
Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.
- Class
- Class I
- Most serious
- Status
- Terminated
- Closed 08/05/2025
- Recall started
- 09/30/2024
- Distribution
- Nationwide
Reason for recall
Presence of Particulate Matter: Presence of glass particulates.
Class I: A reasonable chance that using or being exposed to the product will cause serious health problems or death.
Recalled product
- Product
- Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317
- Lot and code info
- Lot #SP2400058, Exp 12/31/2024
- Quantity
- 4773 vials
- Recall number
- D-0040-2025
- Event ID
- 95503
- Initiated by
- Voluntary: Firm initiated
Where it was distributed
Nationwide in the USA
- Nationwide
Recall timeline
- 09/30/2024Firm started the recall
- 11/07/2024FDA classified it as Class I
- 11/13/2024Published in the FDA enforcement report
- 08/05/2025FDA closed (terminated) the recall
Frequently asked questions
- Why was Ascorbic Acid Inj. Solution recalled?
- Presence of Particulate Matter: Presence of glass particulates.
- What does Class I mean?
- Class I is FDA's most serious recall category: a reasonable chance that using or being exposed to the product will cause serious health problems or death.
- Where was the recalled product sold?
- Nationwide in the USA
- Is this recall still active?
- The FDA lists the recall as terminated (closed 08/05/2025). FDA has determined the recall is complete and closed it.
Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 11/13/2024 · Do not rely on openFDA to make decisions regarding medical care